Figures & data
*P < 0.05, **P < 0.01, ***P < 0.001, compared to the control and healthy groups. #P < 0.05, ##P < 0.01, compared with the LPS-PG group.
*P < 0.05, **P < 0.01, compared with si-nc and the control group. #P < 0.05, ##P < 0.01, compared with the LPS-PG group. &P < 0.05, &&P < 0.01, compared with the LPS-PG + Ferrostatin-1 + si-nc group. The scale length is 200 μm.
**P < 0.01, compared with nc inhibitor and control group. #P < 0.05, ##P < 0.01, compared with the LPS-PG + si-LINC00616 + nc inhibitor group. The scale length is 200 μm.
Supplemental material